Latest Asx News

ECS Botanics is strategically preparing for entry into the US medicinal cannabis market, leveraging its EU-GMP certification and proprietary genetics amid evolving regulatory landscapes.

Augustus Minerals announces the sudden resignation of CEO Dr James Warren, with interim leadership stepping in as the company begins its search for a successor.

Bank of Queensland Limited has announced a fully franked quarterly distribution of AUD 1.2412 per Capital Note 3 security, payable in March 2026. The distribution reflects a 4.9784% annualised rate based on the BBSW plus a margin.

3D Energi has raised $14.5 million through a well-supported placement to fund critical drilling and testing activities in the Otway Basin, aiming to unlock new gas reserves for Australia's East Coast market.

Theta Gold Mines has entered a non-binding agreement for an $80 million USD senior secured loan to fully fund its TGME Gold Mine Project, aiming for first gold pour in early 2027. The deal includes flexible funding tranches and equity-linked warrants.

Bulletin Resources has sold three non-core tenements of its Lake Rebecca Gold Project to Ramelius Resources for $500,000, enabling a strategic focus on its larger, recently acquired gold ground. The company remains well funded and is advancing exploration plans on high-potential targets.

Yugo Metals Limited has secured a dual listing on Germany’s Frankfurt and Dusseldorf Stock Exchanges, enhancing its access to European investors, while initial drilling at its Sinjakovo Project in Bosnia-Herzegovina reveals encouraging silver-lead-zinc mineralisation.

American Rare Earths has successfully produced mixed rare earth oxides from Halleck Creek ore, marking a pivotal technical breakthrough in its mineral processing program. This achievement advances the project closer to commercial viability amid growing demand for critical minerals.

Emyria has secured its first Empax clinic in Victoria, marking a significant step in its multi-state expansion and validating its scalable, reimbursed national mental health platform.

Forrestania Resources’ Phase 3 drilling at the Ada Ann prospect reveals significant high-grade gold mineralisation beyond the maiden resource, supporting potential resource growth at the Bonnie Vale Project.

Centrepoint Alliance forecasts a robust 13% increase in EBITDA for the first half of FY26, driven by strong adviser recruitment and platform scaling, cementing its position as the second-largest licensee in Australia.

Entropy Neurodynamics has successfully completed dosing the first patient in its TRP-8803 clinical trial for Binge Eating Disorder, marking a key milestone with controlled psychedelic infusion and safety clearance. Top-line results are expected in early 2026.